Q3 2025 Milestone Scientific Inc Earnings Call Transcript
Key Points
- Milestone Scientific Inc (MLSS) reduced operating expenses by over $50 million compared to the same period last year while maintaining stable revenue performance.
- The company made solid progress in expanding direct sales programs in North America and advancing international registrations for its STA single tooth anesthesia system.
- International dental sales increased year over year, partially offsetting the decline in domestic revenue.
- The addition of Doctor Dawud Syed to the board of directors strengthens the company's clinical and payer expertise, supporting its strategy to accelerate adoption within hospital systems and integrated pain networks.
- Milestone Scientific Inc (MLSS) secured Medicare payment rate assignments under CPT code 0770 in three jurisdictions, including large population states like New Jersey, Texas, and Florida.
- Revenue for the third quarter was slightly down compared to the same period in 2024, indicating challenges in achieving revenue growth.
- The company faces challenges in convincing dental clinics to invest in new equipment due to economic concerns.
- Utilization of Compuflow disposables has only slightly rebounded, indicating slow progress in re-energizing current customers.
- The company has faced historical challenges in translating successful trials and demos into actual sales.
- Milestone Scientific Inc (MLSS) has experienced a decline in domestic dental revenue, which has not been fully offset by international sales growth.
Greetings and welcome to the milestone Scientific 3rd quarter 2025 financial results and business update call.
At this time, all participants are placed on a listen-only mode, and a question-and-answer session will follow the formal presentation.
If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. And please note, this conference is being recorded.
I will now turn the conference over to your host, Mr. David Waldman. Sir, the floor is yours.
Thank you. Good morning and I appreciate everyone joining Milestone Scientific's 3rd quarter 2025 financial results conference call. On the call with us today are Eric Hines, Chief Executive Officer, and Keisha Harcom, Vice President of Finance of Milestone Scientific. The company issued a press release this yesterday after market containing 3rd quarter 2025 financial results, which is also posted on the company's website. If you have any questions after the call, would like
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
